Astera Labs (NASDAQ:ALAB) Shares Up 3.4% – Here’s What Happened

Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) shares traded up 3.4% on Monday. The stock traded as high as $365.24 and last traded at $362.34. Approximately 3,232,048 shares were traded during trading, a decline of 38% from the average daily volume of 5,184,580 shares. The stock had previously closed at $350.33.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on ALAB shares. Barclays increased their price objective on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Morgan Stanley lifted their price objective on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Finally, Roth Capital reissued a “buy” rating and issued a $450.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $348.33.

View Our Latest Stock Analysis on ALAB

Astera Labs Trading Up 3.4%

The company has a market capitalization of $62.86 billion, a price-to-earnings ratio of 179.38 and a beta of 3.68. The company’s 50 day simple moving average is $309.04 and its 200-day simple moving average is $283.09.

Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the prior year, the company posted $0.44 EPS. The business’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $274.96, for a total transaction of $2,472,990.24. Following the sale, the director directly owned 3,309 shares in the company, valued at $909,842.64. This trade represents a 73.10% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 396,059 shares of company stock worth $122,605,660. Corporate insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

Hedge funds and other institutional investors have recently modified their holdings of the business. QRG Capital Management Inc. increased its holdings in Astera Labs by 8.7% during the 2nd quarter. QRG Capital Management Inc. now owns 4,775 shares of the company’s stock worth $2,306,000 after purchasing an additional 381 shares during the last quarter. Silicon Valley Capital Partners raised its position in shares of Astera Labs by 99.0% in the 2nd quarter. Silicon Valley Capital Partners now owns 1,990 shares of the company’s stock valued at $961,000 after purchasing an additional 990 shares in the last quarter. Twin Peaks Capital Ltd purchased a new position in shares of Astera Labs during the 2nd quarter valued at approximately $4,830,000. Capstone Financial Advisors Inc. acquired a new stake in shares of Astera Labs during the second quarter worth approximately $274,000. Finally, Sequoia Financial Advisors LLC grew its position in shares of Astera Labs by 19.0% during the second quarter. Sequoia Financial Advisors LLC now owns 3,677 shares of the company’s stock worth $1,776,000 after buying an additional 588 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.

Recommended Stories

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.